HCTI Healthcare Triangle, Inc.
Services-Computer Integrated Systems Design · Nasdaq · SEC CIK 1839285 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY141.9%
TTM net income YoY-179.2%
TTM EPS YoY112.9%
Revenue 3-yr CAGR-5.8%
Net income 3-yr CAGR—
Margins
Gross margin548.0%
Operating margin-45.2%
Net margin-56.4%
FCF margin—
EBITDA margin-38.6%
Returns
ROE-59.7%
ROA-40.8%
ROIC (approx.)-32.6%
Asset turnover0.72x
Leverage & solvency
Liabilities / assets30.9%
Debt / equity0.26x
Current ratio0.62x
Interest coverage-40.05x
Cash quality & payout
Operating cash flow / net income0.97x
Accruals ratio-1.4%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $13.89M | $11.70M |
| Cost of revenue | $12.00M | $8.81M |
| Gross profit | $1.24B | $1.07B |
| R&D expense | $536,000 | $429,000 |
| SG&A expense | $7.34M | $3.95M |
| Operating income | -$9.79M | -$4.75M |
| Interest expense | $567,000 | — |
| Pretax income | -$9.48M | -$5.96M |
| Income tax | — | $12,000 |
| Net income | -$9.48M | -$5.97M |
| EBITDA | -$9.08M | -$3.86M |
| EPS (basic) | -152.30 | -16,909.30 |
| EPS (diluted) | -152.30 | -16,909.30 |
| Weighted avg. shares (diluted) | 61,873 | 353 |
| Banking | ||
| Net interest income | -$567,000 | -$1.21M |
| Balance sheet | ||
| Cash & equivalents | $7.62M | $20,000 |
| Receivables | $2.07M | $1.11M |
| Current assets | $13.15M | $1.45M |
| PP&E, net | $5,000 | $12,000 |
| Goodwill | $2.95M | — |
| Intangibles | $2.81M | — |
| Total assets | $22.74M | $1.96M |
| Current liabilities | $12.79M | $7.08M |
| Short-term debt | $10.74M | $2.65M |
| Total liabilities | $12.79M | $7.08M |
| Shareholders' equity | $9.98M | -$5.11M |
| Shares outstanding | 7,121 | 380 |
| Cash flow statement | ||
| Operating cash flow | -$16.52M | -$1.08M |
| Capital expenditure | $6,000 | — |
| Free cash flow | -$16.53M | — |
| Investing cash flow | -$1.75M | — |
| Financing cash flow | $25.88M | -$133,000 |
| Depreciation & amortization | $705,000 | $889,000 |
| Stock-based compensation | $451,000 | $87,000 |
Free plan shows the latest 2 periods; Pro shows all 6 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.